Abstract Targeted Auger Therapy represents great potential for the therapy of diseases
which require a high degree of selectivity on the cellular level (eg for therapy of metastatic …

Cancer is a leading cause of morbidity and mortality in the modern world. Treatment
modalities comprise radiation therapy, surgery, chemotherapy and hormonal therapy …

Targeted Radionuclide Therapies (TRTs) based on Auger emitting radionuclides have the
potential to deliver extremely selective therapeutic payloads on the cellular level. However …

Abstract Antimony‐119 (119Sb) holds promise for radiopharmaceutical therapy (RPT),
emitting short‐range Auger and conversion electrons that can deliver cytotoxic radiation on …

Background Radiopharmaceutical therapy (RPT) uses radionuclides that decay via one of
three therapeutically relevant decay modes (alpha, beta, and internal conversion (IC)/Auger …

Abstract Targeted Meitner-Auger Therapy (TMAT) has potential for personalized treatment
thanks to its subcellular dosimetric selectivity, which is distinct from the dosimetry of β− and α …

Only very few radionuclides exist that decay exclusively by EC-mode without accompanying
radiation, 119Sb is one of them. Auger emitter 119Sb (T1/2= 38.9 h, IEC= 100%) is a potent …

Radionuclides find widespread use in medical technologies for treating and diagnosing
disease. Among successful and emerging radiotherapeutics, 119Sb has unique potential in …

Cross sections of a prospective medical radionuclide 117mSn along with 113Sn, 120m,
122Sb, 111,114 mIn and 118,119 m, 119g, 121m, 121g, 123mTe generated in natural and …

The survey considers radionuclides emitting short-range particles. Methods for the
production of most promising $\alpha $-and Auger electron emitters and their applications in …